Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City.
作者信息
Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, Cruz C
机构信息
Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, USA.
Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, NY, USA.
出版信息
Ann Oncol. 2020 Aug;31(8):1088-1089. doi: 10.1016/j.annonc.2020.04.006. Epub 2020 Apr 21.
Abstract
摘要
相似文献
1
Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City.癌症患者的新冠病毒病预后是否更差？纽约市的一项经验。
Ann Oncol. 2020 Aug;31(8):1088-1089. doi: 10.1016/j.annonc.2020.04.006. Epub 2020 Apr 21.
2
Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City.纽约市一家学术中心诊断为感染新冠病毒的乳腺癌患者的特征及预后
Breast Cancer Res Treat. 2020 Jul;182(1):239-242. doi: 10.1007/s10549-020-05667-6. Epub 2020 May 14.
3
Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.2020 年 3 月 11 日至 5 月 2 日期间 COVID-19 爆发期间超额死亡的初步估计-纽约市。
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):603-605. doi: 10.15585/mmwr.mm6919e5.
4
Comparison of Estimated Excess Deaths in New York City During the COVID-19 and 1918 Influenza Pandemics.比较 COVID-19 与 1918 年流感大流行期间纽约市预估超额死亡人数。
JAMA Netw Open. 2020 Aug 3;3(8):e2017527. doi: 10.1001/jamanetworkopen.2020.17527.
5
Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China.中国新冠肺炎死亡患者的临床特征。
JAMA Netw Open. 2020 Apr 1;3(4):e205619. doi: 10.1001/jamanetworkopen.2020.5619.
6
COVID-19 morbidity and mortality in 2020: the case of the city of Rio de Janeiro.2020年新型冠状病毒肺炎的发病率和死亡率：以里约热内卢市为例
J Bras Pneumol. 2020 Nov 2;46(5):e20200341. doi: 10.36416/1806-3756/e20200341.
7
The presence of heart disease worsens prognosis in patients with COVID-19.心脏病的存在会使新冠肺炎患者的预后恶化。
Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):773-775. doi: 10.1016/j.rec.2020.05.025. Epub 2020 Jun 19.
8
Machine Learning to Predict Mortality and Critical Events in a Cohort of Patients With COVID-19 in New York City: Model Development and Validation.机器学习预测纽约市新冠肺炎患者队列中的死亡率和危急事件：模型开发与验证
J Med Internet Res. 2020 Nov 6;22(11):e24018. doi: 10.2196/24018.
9
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19.新冠病毒肺炎住院患者治疗剂量抗凝与院内生存的相关性
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124. doi: 10.1016/j.jacc.2020.05.001. Epub 2020 May 6.
10
Denominator matters in estimating COVID-19 mortality rates.在估算新冠病毒病死亡率时，分母很重要。
Eur Heart J. 2020 Oct 1;41(37):3500. doi: 10.1093/eurheartj/ehaa282.
引用本文的文献
1
Impact of Cancer Subtype and Cancer Therapy Exposures on SARS-CoV-2 Outcomes in the Omicron and Subvariant Era.癌症亚型和癌症治疗暴露对奥密克戎及其亚型流行时代严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染结局的影响
Cancer Med. 2025 Jul;14(14):e71082. doi: 10.1002/cam4.71082.
2
Development and application of a UHPLC-MS/MS method for the simultaneous determination of firmonertinib and its main metabolite AST-5902 in rat plasma: a study on the drug interaction between firmonertinib and paxlovid.超高效液相色谱-串联质谱法同时测定大鼠血浆中伏美替尼及其主要代谢产物AST-5902的方法开发与应用：伏美替尼与帕罗韦德药物相互作用的研究
Front Pharmacol. 2025 May 12;16:1570206. doi: 10.3389/fphar.2025.1570206. eCollection 2025.
3
Association of Cancer History with COVID-19 Risk and Outcomes among Older Postmenopausal Women: Results from the Women's Health Initiative.绝经后老年女性癌症病史与 COVID-19 风险及预后的关联：妇女健康倡议的结果
Cancer Epidemiol Biomarkers Prev. 2025 Aug 1;34(8):1286-1294. doi: 10.1158/1055-9965.EPI-24-1682.
4
Sociodemographic, medical, health behavior, and psychosocial factors associated with COVID-19 diagnoses in the New Jersey cancer survivor cohort.新泽西州癌症幸存者队列中与新冠病毒疾病（COVID-19）诊断相关的社会人口学、医学、健康行为和心理社会因素。
Cancer Causes Control. 2025 Apr 25. doi: 10.1007/s10552-025-01997-2.
5
Differences in COVID-19-Related Hospitalization, Treatment, Complications, and Death by Race and Ethnicity and Area-Level Measures Among Individuals with Cancer in the ASCO Registry.美国临床肿瘤学会（ASCO）登记处中癌症患者因种族、民族及地区层面指标在与新冠病毒病（COVID-19）相关的住院治疗、并发症和死亡方面存在的差异。
Cancers (Basel). 2025 Mar 2;17(5):857. doi: 10.3390/cancers17050857.
6
COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study.COVID-19疫情封锁相关的治疗调整未影响消化道癌症的治疗结果：Clin-COVIDICA前瞻性研究
BMC Cancer. 2025 Mar 5;25(1):398. doi: 10.1186/s12885-025-13787-9.
7
Prognostic Factors for Survival or Severity After COVID-19 Infection in Cancer Patients: A Systematic Review and Meta-Analysis.癌症患者感染新型冠状病毒肺炎后的生存或严重程度的预后因素：一项系统评价和荟萃分析
J Rhinol. 2023 Jul;30(2):69-79. doi: 10.18787/jr.2023.00015. Epub 2023 Jul 28.
8
Outcomes of Cancer Patients Affected by COVID-19 in Different Settings: A Retrospective Study in Lebanon.不同环境下 COVID-19 对癌症患者的影响结果：黎巴嫩的一项回顾性研究。
Cancer Rep (Hoboken). 2024 Nov;7(11):e70045. doi: 10.1002/cnr2.70045.
9
Cancer nurses' experience during the COVID-19 pandemic: Multicenter mixed-methods study on coping and resilience strategies.癌症护士在 COVID-19 大流行期间的经历：关于应对和复原力策略的多中心混合方法研究
BMC Nurs. 2024 Jul 23;23(1):502. doi: 10.1186/s12912-024-02085-7.
10
Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer.抗血管生成药物对非小细胞肺癌患者新冠病毒病严重程度的影响
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241248573. doi: 10.1177/15330338241248573.
本文引用的文献
1
COVID-19 infection in cancer patients: early observations and unanswered questions.癌症患者中的新型冠状病毒肺炎感染：早期观察与未解决的问题。
Ann Oncol. 2020 Jul;31(7):838-839. doi: 10.1016/j.annonc.2020.03.297. Epub 2020 Mar 31.
2
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.COVID-19 感染癌症患者的临床特征：中国武汉三家医院的回顾性病例研究。
Ann Oncol. 2020 Jul;31(7):894-901. doi: 10.1016/j.annonc.2020.03.296. Epub 2020 Mar 26.
3
Risk of COVID-19 for patients with cancer.癌症患者感染新型冠状病毒肺炎的风险。
Lancet Oncol. 2020 Apr;21(4):e180. doi: 10.1016/S1470-2045(20)30150-9. Epub 2020 Mar 3.
4
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
5
Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.癌症免疫编辑：整合免疫在癌症抑制和促进中的作用。
Science. 2011 Mar 25;331(6024):1565-70. doi: 10.1126/science.1203486.
Zotero 插件